共 60 条
[1]
Aozasa K(2008)Nasal NK/T-cell lymphoma: epidemiology and pathogenesis Int J Hematol 87 110-117
[2]
Takakuwa T(2013)First-line combination of gemcitabine, oxaliplatin, and Cancer 119 348-355
[3]
Hongyo T(2012)-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma J Clin Oncol 30 4044-4046
[4]
Wang L(1995)Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211 Cancer 76 2351-2356
[5]
Wang ZH(2011)Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells Blood 117 1834-1839
[6]
Chen XQ(2014)GELA and GOELAMS Intergroup. Efficacy of Ann Hematol 93 1889-1894
[7]
Yamaguchi M(2012)-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study Blood 120 2973-2980
[8]
Tobinai K(2013)Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients Investig New Drugs 31 469-472
[9]
Oguchi M(2013)SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group Leuk Lymphoma 54 1194-1200
[10]
Yamaguchi M(2012)Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma Curr Pharm Des 18 2811-2829